Document Detail


Cytokine production of stimulated whole blood cultures in rheumatoid arthritis patients receiving short-term infliximab therapy.
MedLine Citation:
PMID:  15804598     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with rheumatoid arthritis (RA) treated with anti-tumor necrosis factor (TNF) strategies have an increased susceptibility to infections, especially those caused by intracellular pathogens. In this study we assessed the cytokine production capacity in patients with RA and we further investigated whether anti-TNF therapy modulates the production of pro-inflammatory cytokines involved in the resistance against infections. Whole blood cultures from 10 RA patients and 10 healthy controls were stimulated with heat-killed Candida albicans, Salmonella typhimurium, Staphyloccocus aureus, Aspergillus fumigatus or Mycobacterium tuberculosis and production of interleukin (IL)-1beta, IL-6, IL-10, interferon (IFN)-gamma and TNF-alpha was measured. Before anti-TNF therapy, whole blood cultures from RA patients released significantly less IFN-gamma than healthy controls after stimulation with all tested microorganisms. Short-term anti-TNF therapy did not have an inhibitory effect on the release of the cytokines tested. We conclude that cells of patients with RA have a strongly reduced production capacity of IFN-gamma after bacterial challenge. Although short-term therapy with anti-TNF agents did not further decrease the release of other proinflammatory cytokines, the combination of defective IFN-gamma production in basal conditions and TNF neutralization during anti-TNF therapy is likely to be responsible for the higher susceptibility to infections in patients with RA.
Authors:
Calin Popa; Mihai G Netea; Pilar Barrera; Timothy R D S Radstake; Piet L van Riel; Bart-Jan Kullberg; Jos W M Van der Meer
Related Documents :
15332768 - New biochemical markers in chronic heart failure.
16891858 - Impact of tnf-alpha and il-6 levels on development of cachexia in newly diagnosed nsclc...
19639518 - Association of helicobacter pylori infection with systemic inflammation in preeclampsia.
9657468 - Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart f...
7954418 - In vivo modulation of macrophage tumoricidal activity by oral administration of the lip...
2682038 - The effect of tumor necrosis factor alpha on the activity of lipoprotein lipase in adip...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cytokine     Volume:  30     ISSN:  1043-4666     ISO Abbreviation:  Cytokine     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-04     Completed Date:  2005-07-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9005353     Medline TA:  Cytokine     Country:  United States    
Other Details:
Languages:  eng     Pagination:  72-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, University Medical Center St. Radboud, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Monoclonal / pharmacology*,  therapeutic use
Antirheumatic Agents / pharmacology*,  therapeutic use
Arthritis, Rheumatoid / blood*,  drug therapy,  immunology
Aspergillus fumigatus / pathogenicity
Blood Cells / drug effects,  immunology,  metabolism*,  microbiology
Candida albicans / pathogenicity
Case-Control Studies
Cytokines / blood*
Humans
Inflammation Mediators / blood
Mycobacterium tuberculosis / pathogenicity
Reference Values
Salmonella typhimurium / pathogenicity
Tumor Necrosis Factor-alpha / drug effects,  immunology
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Antirheumatic Agents; 0/Cytokines; 0/Inflammation Mediators; 0/Tumor Necrosis Factor-alpha; 0/infliximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of MCP-1 depletion on chemokine and chemokine-related gene expression: evidence for a com...
Next Document:  Recombinant rat IL-1beta and IL-6 synergistically enhance C3 mRNA levels and complement component C3...